-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TTAX-03 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TTAX-03 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TTAX-03 in Osteoarthritis Pain Drug Details: TTAX-03 is under development for the...
-
Sector Analysis
NewAsia-Pacific (APAC) Sport Technology Sponsorship Landscape – Analysing Biggest Deals, Sports League, Brands and Case Studies
APAC Sport Technology Sponsorship Landscape Report Overview The annual deal value in the APAC sports technology sponsorship market was $3.63 million in 2024. Technology companies are joining forces with prominent athletic events and organizations. They are doing this to showcase their latest innovations. Technology is always developing and growing. From fan apps to virtual reality, technology has permeated every facet of sports technology. The APAC sport technology sponsorship report provides an overview of the sector across the APAC region. It...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – XT-150 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XT-150 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XT-150 in Osteoarthritis Pain Drug Details: XT-150 is under development for the...
-
Product Insights
NewSpinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Sector Analysis
Spinal Non-Fusion Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Spinal Non-Fusion Market Report Overview The spinal non-fusion market size was $884.8 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Spinal non-fusion surgery is performed to treat spinal instability, degenerative disc disorder, and spinal stenosis while preserving the spine's normal motion, load bearing, and shock absorption capacity. Spinal non-fusion surgery also provides pain relief without major anatomical removal. Spinal Non-Fusion Market Outlook, 2023-2033 ($ Million) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TTAX-03 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TTAX-03 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TTAX-03 in Osteoarthritis Pain Drug Details:TTAX-03 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-001 in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-001 in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Ulcerative Colitis Drug Details: DB-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-001 in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-001 in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Crohn's Disease (Regional Enteritis) Drug Details: DB-001 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-001 in Acute Respiratory Distress Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-001 in Acute Respiratory Distress Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-001 in Acute Respiratory Distress Syndrome Drug Details: DB-001 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XT-150 in Neuropathic Pain (Neuralgia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XT-150 in Neuropathic Pain (Neuralgia) Drug Details:XT-150 is under development for the treatment of neuropathic pain,...